NovaBay Pharmaceuticals (NYSEMKT:NBY) just reported results for the first quarter of 2024.
- NovaBay Pharmaceuticals reported earnings per share of -14 cents. This was above the analyst estimate for EPS of -15 cents.
- The company reported revenue of $2.63 million.
- This was 19.79% worse than the analyst estimate for revenue of $3.28 million.